Where to Watch
Where To Watch
Hawthorne Effect Raises $20 Million Series A to Decentralize Clinical Trials
Jun 11, 2021 06:33 pm
Jodi Akin, founder and CEO of Hawthorne Effect, discusses what comes next for the clinical trials company following a Series A funding round of $20 million.
Grand Rounds Health and Doctor on Demand Announce Rebrand to 'Included Health'
Online Professional Coaching Platform BetterUp CEO on $300M Fundraise
Walgreens: U.S. Flu Cases Up 23% This Year
Stocks End Mixed on Wall Street, Still Notch Weekly Gains
Terms of Service
Follow us on
© 2021 Cheddar, Inc.